| WKN: | A1W15D |
| ISIN: | US00182C1036 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Ani Pharmaceuticals-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 04. Januar 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2014 | 14,22 | 43,67 | 207,10% |
| 2 | 2013 | 5,60 | 14,22 | 153,93% |
| 3 | 2021 | 22,80 | 41,00 | 79,82% |
| 4 | 2019 | 36,83 | 56,50 | 53,41% |
| 5 | 2016 | 43,15 | 59,15 | 37,08% |
| 6 | 2025 | 51,00 | 67,50 | 32,35% |
| 7 | 2007 | 73,80 | 97,56 | 32,20% |
| 8 | 2023 | 38,20 | 49,00 | 28,27% |
| 9 | 2009 | 28,80 | 36,00 | 25,00% |
| 10 | 2010 | 36,00 | 42,05 | 16,81% |
| 11 | 2024 | 49,00 | 51,00 | 4,08% |
| 12 | 2015 | 43,67 | 43,15 | -1,19% |
| 13 | 2026 | 67,50 | 65,50 | -2,96% |
| 14 | 2022 | 41,00 | 38,20 | -6,83% |
| 15 | 2017 | 59,15 | 52,27 | -11,63% |
| 16 | 2005 | 138,60 | 106,56 | -23,12% |
| 17 | 2018 | 52,27 | 36,83 | -29,54% |
| 18 | 2006 | 106,56 | 73,80 | -30,74% |
| 19 | 2012 | 13,32 | 5,60 | -57,96% |
| 20 | 2020 | 56,50 | 22,80 | -59,65% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2008 | 97,56 | 28,80 | -70,48% |
| 2 | 2011 | 42,05 | 13,32 | -68,32% |
| 3 | 2020 | 56,50 | 22,80 | -59,65% |
| 4 | 2012 | 13,32 | 5,60 | -57,96% |
| 5 | 2006 | 106,56 | 73,80 | -30,74% |
| 6 | 2018 | 52,27 | 36,83 | -29,54% |
| 7 | 2005 | 138,60 | 106,56 | -23,12% |
| 8 | 2017 | 59,15 | 52,27 | -11,63% |
| 9 | 2022 | 41,00 | 38,20 | -6,83% |
| 10 | 2026 | 67,50 | 65,50 | -2,96% |
| 11 | 2015 | 43,67 | 43,15 | -1,19% |
| 12 | 2024 | 49,00 | 51,00 | 4,08% |
| 13 | 2010 | 36,00 | 42,05 | 16,81% |
| 14 | 2009 | 28,80 | 36,00 | 25,00% |
| 15 | 2023 | 38,20 | 49,00 | 28,27% |
| 16 | 2007 | 73,80 | 97,56 | 32,20% |
| 17 | 2025 | 51,00 | 67,50 | 32,35% |
| 18 | 2016 | 43,15 | 59,15 | 37,08% |
| 19 | 2019 | 36,83 | 56,50 | 53,41% |
| 20 | 2021 | 22,80 | 41,00 | 79,82% |